Consumers should take precautions if they are one of the 40 million Target customers whose credit card data was breached this holiday shopping season.» Read More
Dr. Leonard Schleifer, Regeneron Pharmaceuticals president & CEO, discusses competition in the pharma sector and upcoming clinical trials. "One of the things that's particularly exciting for a lot of people is our approach to lowering cholesterol," says Schleifer.
CNBC's Seema Mody discusses the details of the deal between pharma companies Bristol-Myers and Amylin.
Half of marriages end in divorce, and as many as 67 percent of second marriages, and 74 percent of third marriages also fail, reports CNBC's Brian Shactman.
CNBC's Rick Santelli discusses bond prices and yields.
CNBC's Tyler Mathisen and Matt Cheslock of Virtu Financial break down today's major analyst calls, including Deutsche Bank downgrading UPS to a "hold."
CNBC's Julia Boorstin reports on superheroes in July and political ad spending for the small screen.
CNBC's Scott Cohn reports on what the Justice Department calls the biggest health care fraud settlement in U.S. history; and CNBC's Seema Mody reports on the details of Bristol-Myers' plans to buy Amylin.
CNBC's Herb Greenberg has the latest details on why education stocks are moving higher, and how to play the legal ruling, with the FMHR traders.
CNBC's Kayla Tausche has the outlook on the financial sector in the third quarter and how to play them, with the FMHR traders.
Laura Champine, Canaccord Genuity analyst, explains why the recent pullback in the luxury retailer presents a buying opportunity for investors; and the best way to play Treasury bonds, with Brian Rehling, Wells Fargo Advisors.
The FMHR crew weigh in with their top three trades today, and a look at under-the-radar tech stocks, with Zack Shafran, Ivy Science & Technology Fund.
The FMHR traders provide their top pharma trades, and CNBC's Courtney Reagan reports on Wal-Mart's controversial 50-year climb toward becoming the world's largest retailer. Also, Chuck Grom, Deutsche Bank analyst, explains why he downgraded Dollar Tree to "hold," and the best way to play the retail space.
The FMHR traders weigh in on how to play today's weak manufacturing numbers; Goldman's call on an eight-percent drop in the S&P. Also, China's soft economic data. And Mark Schoenebaum, ISI Group analyst, discusses the merger between Bristol-Myers and Amylin Pharma and whether the pharma sector is on the verge of consolidation.
CNBC's Mary Thompson and Art Cashin, of UBS, discuss today's weak ISM data as well as the PMI data in Europe. The important thing, he says, is there haven't been any really big negatives out of Europe.
Are electronic stores on the verge of extinction? Jeff Jordan, Andreessen Horowitz, weighs in on whether it's only a matter of time before e-commerce replaces physical retail.
Helen Zhu, Goldman Sachs chief China equity strategist, discusses where to find opportunities in spite of China's economic slowdown.
The trade on the giant retailer and whether the company can keep its momentum going, with Deborah Weinswig, Citi retail analyst, and Robert Carroll, UBS retail analyst.
A look at how the world's largest guitar maker has not missed a single beat since the dawn of rock and roll, with Henry Juszkiewicz, Gibson Guitar CEO.
CNBC's Courtney Reagan reports on how the nation's largest retailer has grown over the years and whether it is hurtful for the rest of the retail space.
Jostein Solheim, Ben & Jerry's CEO, discusses his company's plan to hire at the main plant in Vermont, and America's growing appetite for Greek frozen yogurt.